TNXP Tonix Pharmaceuticals Holding C
$5.37▼ -0.37%
Healthcare
Other
After hours
$5.26▼ -2.05%
Oct 28, 5:50 PM ET
Volume 572.2K
Avg Volume (10D) 1.10M
Key Metrics & Fundamentals
Market Cap
$92.10M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.01 - 20.56
% vs 50 MA
-45.37%
% vs 200 MA
-57.32%
RSI-14
19.1
MACD Histogram
+0.0600
Beta (1Y vs SPY)
1.85
Free Cash Flow
-$42.83M
Gross Rev
$13.54M
Gross Profit
$12.84M
EBITDA
-$41.32M
COGS
$703,000
Operating Exp
$54.78M
Operating Income
-$41.94M
EBIT
-$41.94M
Pretax Income
-$40.55M
Net Income
-$40.55M
EPS (Diluted)
-2.44
Price & Volume History
Loading chart…
Recent News
Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
GlobeNewswire · Oct 27, 2026 7:00 AM ET
Canaccord Genuity Initiates Coverage on Tonix Pharmaceuticals With Buy Rating, $18 Price Target
MT Newswires · Oct 26, 2026 7:39 AM ET
Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
GlobeNewswire · Oct 26, 2026 7:00 AM ET
A New Fibromyalgia Drug Deal Reaches 21 Million More Medicare Lives. Her Own Plan Could Still Decide What She Pays
24/7 Wall St. · Oct 22, 2026 6:00 AM ET
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
GlobeNewswire · Oct 19, 2026 7:00 AM ET
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
GlobeNewswire · Oct 15, 2026 7:00 AM ET
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
GlobeNewswire · Sep 22, 2026 7:00 AM ET
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears
MarketBeat · Sep 11, 2026 10:01 PM ET
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
GlobeNewswire · Sep 8, 2026 7:00 AM ET
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
Zacks Small Cap Research · Sep 2, 2026 9:38 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TNXP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.